Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.


Investor type Venture Capital


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 13
Average round size
The average size of a deal this fund participated in
Portfolio companies 13
Rounds per year 1.86
Lead investments 0
Key employees Soon

Areas of investment

  • Medical Device
  • Health Care
  • Biotechnology
  • Medical
  • Health Diagnostics

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of BIOCHING CAPITAL:
Typical Co-investors
BIOCHING CAPITAL is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after BIOCHING CAPITAL:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Argonaut Holdings Detroit, Michigan, United States
Arthurian Life Sciences England, London, United Kingdom
Axel Johnson New York, New York, United States
Axiometrics Dallas, Texas, United States
Binhai Capital China, Guangdong, Tianjin
Gateway Partners Central, Central Region, Singapore
Growth Catalyst Partners Chicago, Illinois, United States
Hengtai Securities China, Hohhot, Nei Mongol
Longmont Capital, Ltd Houston, Texas, United States
Natural Sciences and Engineering Research Council of Canada (NSERC) -
NPIF - FW Capital Debt Finance Birmingham, England, United Kingdom
Omni Prime China, Shanghai
Osbon Capital Management Boston, Massachusetts, United States
Polymath Ventures Buenaventura, Colombia, Valle del Cauca
Pulte Home Corp Atlanta, Georgia, United States
Ranwa Technologies Co. -
RTL Ventures Hilversum, Noord-Holland, The Netherlands
Ruiqi Investment China, Hong Kong, Hong Kong Island
VinaCapital Ventures Chicago, Illinois, United States
Xterra Inc California, San Francisco, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Yinghe Brain Science

Health Care
Medical Device
$100M23 Jan 2023 Shenzhen, Guangdong, China

Yisimei Technology

Health Care
Medical Device
01 Jan 2021 Shenzhen, Guangdong, China


Clinical Trials
Medical Device
$463K09 Oct 2018 Qingyang District, Sichuan, China

$7M11 Feb 2018 Futian District, Guangdong Province

INLEMS Technologie

01 Jan 2018 Shenzhen, Guangdong, China

Test and Measurement
01 Nov 2016 Shanghai, China


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent BIOCHING CAPITAL?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: